H7N9 and Influenza A Viral Load Quantitative Test
Test Name: H7N9 and Influenza A Viral Load Quantitative Test
Components: Sputum; throat and nasal swabs in viral transport medium, or lung tissues, Cell Cultures etc.
Price: 2310.0 AED
Sample Condition: Sputum; throat and nasal swabs in viral transport medium, or lung tissues, Cell Cultures etc.
Report Delivery: 4th Working Day (Email: 48 hours, On phone: 36 hours)
Method: Real Time PCR
Test Type: Viral
Doctor: Physician
Test Department: Genetics
Pre Test Information: Need to sign Consent document and bring any clinical history of patient for H7N9 & Influenza A Viral Load Quantitative Test
Test Details
The H7N9 and Influenza A Viral Load Quantitative Test is a diagnostic test used to measure the amount of H7N9 and Influenza A viruses present in a patient’s respiratory samples, such as nasal swabs or sputum. This test is typically performed using a real-time reverse transcription-polymerase chain reaction (RT-PCR) method. The test detects and amplifies specific genetic material (RNA) from the H7N9 and Influenza A viruses in the patient’s sample. The viral load, or the amount of viral genetic material, is then quantified based on the number of amplification cycles required to detect the virus.
The test results provide information on the quantity of H7N9 and Influenza A viruses in the patient’s sample, which can help healthcare providers determine the severity of the infection and guide treatment decisions. High viral loads may indicate a more severe infection, while low viral loads may suggest a milder illness. Quantitative viral load testing is especially useful for monitoring the progress of the infection, assessing the effectiveness of antiviral treatment, and determining the risk of transmission to others. It can also be used to track viral replication dynamics and study the viral kinetics during the course of the infection.
Overall, the H7N9 and Influenza A Viral Load Quantitative Test is an important tool in the diagnosis and management of H7N9 and Influenza A virus infections, providing valuable information for patient care and public health surveillance.
| Test Name | H7N9 and Influenza A Viral Load Quantitative Test |
|---|---|
| Components | |
| Price | 2310.0 AED |
| Sample Condition | Sputum; throat and nasal swabs in viral transport medium, or lung tissues, Cell Cultures etc. |
| Report Delivery | 4th Working Day Email : 48 hours.On phone : 36 hours |
| Method | Real Time PCR |
| Test type | Viral |
| Doctor | Physician |
| Test Department: | Genetics |
| Pre Test Information | Need to sign Consent document and bring any clinical history of patient forH7N9 & Influenza A Viral Load QuantitativeTest |
| Test Details |
The H7N9 and Influenza A Viral Load Quantitative Test is a diagnostic test used to measure the amount of H7N9 and Influenza A viruses present in a patient’s respiratory samples, such as nasal swabs or sputum. This test is typically performed using a real-time reverse transcription-polymerase chain reaction (RT-PCR) method. The test detects and amplifies specific genetic material (RNA) from the H7N9 and Influenza A viruses in the patient’s sample. The viral load, or the amount of viral genetic material, is then quantified based on the number of amplification cycles required to detect the virus. The test results provide information on the quantity of H7N9 and Influenza A viruses in the patient’s sample, which can help healthcare providers determine the severity of the infection and guide treatment decisions. High viral loads may indicate a more severe infection, while low viral loads may suggest a milder illness. Quantitative viral load testing is especially useful for monitoring the progress of the infection, assessing the effectiveness of antiviral treatment, and determining the risk of transmission to others. It can also be used to track viral replication dynamics and study the viral kinetics during the course of the infection. Overall, the H7N9 and Influenza A Viral Load Quantitative Test is an important tool in the diagnosis and management of H7N9 and Influenza A virus infections, providing valuable information for patient care and public health surveillance. |
